NHWA: The hydrochloride of Tizanidine tablets has obtained a drug registration certificate
According to the Zhitong Finance APP, NHWA announced that the company recently obtained the "Drug Registration Certificate" for the chemical drug Tapentadol Hydrochloride Tablets issued by the National Medical Products Administration. Tapentadol Hydrochloride Tablets are used for the treatment of acute pain in adult patients that is severe enough to require the use of opioid analgesics, as well as for acute pain that cannot be adequately relieved by alternative treatments
According to the Zhitong Finance APP, NHWA (002262.SZ) announced that the company recently obtained the "Drug Registration Certificate" for the chemical drug Tapentadol Hydrochloride Tablets issued by the National Medical Products Administration. Tapentadol Hydrochloride Tablets are used for the treatment of acute pain in adult patients that is severe enough to require opioid treatment, as well as for acute pain that is not adequately relieved by alternative treatments
